Literature DB >> 20823256

Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experiments.

Jin Liu1, Gregory E R Weller, Blaine Zern, Portonovo S Ayyaswamy, David M Eckmann, Vladimir R Muzykantov, Ravi Radhakrishnan.   

Abstract

A computational methodology based on Metropolis Monte Carlo (MC) and the weighted histogram analysis method (WHAM) has been developed to calculate the absolute binding free energy between functionalized nanocarriers (NC) and endothelial cell (EC) surfaces. The calculated NC binding free energy landscapes yield binding affinities that agree quantitatively when directly compared against analogous measurements of specific antibody-coated NCs (100 nm in diameter) to intracellular adhesion molecule-1 (ICAM-1) expressing EC surface in in vitro cell-culture experiments. The effect of antibody surface coverage (σ(s)) of NC on binding simulations reveals a threshold σ(s) value below which the NC binding affinities reduce drastically and drop lower than that of single anti-ICAM-1 molecule to ICAM-1. The model suggests that the dominant effect of changing σ(s) around the threshold is through a change in multivalent interactions; however, the loss in translational and rotational entropies are also important. Consideration of shear flow and glycocalyx does not alter the computed threshold of antibody surface coverage. The computed trend describing the effect of σ(s) on NC binding agrees remarkably well with experimental results of in vivo targeting of the anti-ICAM-1 coated NCs to pulmonary endothelium in mice. Model results are further validated through close agreement between computed NC rupture-force distribution and measured values in atomic force microscopy (AFM) experiments. The three-way quantitative agreement with AFM, in vitro (cell-culture), and in vivo experiments establishes the mechanical, thermodynamic, and physiological consistency of our model. Hence, our computational protocol represents a quantitative and predictive approach for model-driven design and optimization of functionalized nanocarriers in targeted vascular drug delivery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20823256      PMCID: PMC2944711          DOI: 10.1073/pnas.1006611107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Designing a polyvalent inhibitor of anthrax toxin.

Authors:  M Mourez; R S Kane; J Mogridge; S Metallo; P Deschatelets; B R Sellman; G M Whitesides; R J Collier
Journal:  Nat Biotechnol       Date:  2001-10       Impact factor: 54.908

2.  Drug delivery systems: entering the mainstream.

Authors:  Theresa M Allen; Pieter R Cullis
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

3.  Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.

Authors:  Tommy Cedervall; Iseult Lynch; Stina Lindman; Tord Berggård; Eva Thulin; Hanna Nilsson; Kenneth A Dawson; Sara Linse
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-31       Impact factor: 11.205

4.  Polyvalent inhibitors of anthrax toxin that target host receptors.

Authors:  Saleem Basha; Prakash Rai; Vincent Poon; Arundhati Saraph; Kunal Gujraty; Mandy Y Go; Skanda Sadacharan; Mia Frost; Jeremy Mogridge; Ravi S Kane
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-28       Impact factor: 11.205

5.  Making polymeric micro- and nanoparticles of complex shapes.

Authors:  Julie A Champion; Yogesh K Katare; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

6.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts.

Authors:  Martin Lundqvist; Johannes Stigler; Giuliano Elia; Iseult Lynch; Tommy Cedervall; Kenneth A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-22       Impact factor: 11.205

7.  Role of particle size in phagocytosis of polymeric microspheres.

Authors:  Julie A Champion; Amanda Walker; Samir Mitragotri
Journal:  Pharm Res       Date:  2008-03-29       Impact factor: 4.200

8.  Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1.

Authors:  Silvia Muro; Thomas Dziubla; Weining Qiu; John Leferovich; Xiumin Cui; Erik Berk; Vladimir R Muzykantov
Journal:  J Pharmacol Exp Ther       Date:  2006-02-27       Impact factor: 4.030

Review 9.  The vascular endothelium. A new horizon.

Authors:  M G Davies; P O Hagen
Journal:  Ann Surg       Date:  1993-11       Impact factor: 12.969

10.  Nucleation of protein fibrillation by nanoparticles.

Authors:  Sara Linse; Celia Cabaleiro-Lago; Wei-Feng Xue; Iseult Lynch; Stina Lindman; Eva Thulin; Sheena E Radford; Kenneth A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-07       Impact factor: 11.205

View more
  52 in total

1.  Effect of flow on endothelial endocytosis of nanocarriers targeted to ICAM-1.

Authors:  Tridib Bhowmick; Erik Berk; Xiumin Cui; Vladimir R Muzykantov; Silvia Muro
Journal:  J Control Release       Date:  2011-09-16       Impact factor: 9.776

2.  Cell and nanoparticle transport in tumour microvasculature: the role of size, shape and surface functionality of nanoparticles.

Authors:  Ying Li; Yanping Lian; Lucy T Zhang; Saad M Aldousari; Hassan S Hedia; Saeed A Asiri; Wing Kam Liu
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

3.  Design of Nanoparticle-Based Carriers for Targeted Drug Delivery.

Authors:  Xiaojiao Yu; Ian Trase; Muqing Ren; Kayla Duval; Xing Guo; Zi Chen
Journal:  J Nanomater       Date:  2016       Impact factor: 2.986

Review 4.  Nanocarrier Hydrodynamics and Binding in Targeted Drug Delivery: Challenges in Numerical Modeling and Experimental Validation.

Authors:  Portonovo S Ayyaswamy; Vladimir Muzykantov; David M Eckmann; Ravi Radhakrishnan
Journal:  J Nanotechnol Eng Med       Date:  2013-07-11

5.  Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium.

Authors:  Poornima Kolhar; Aaron C Anselmo; Vivek Gupta; Kapil Pant; Balabhaskar Prabhakarpandian; Erkki Ruoslahti; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-10       Impact factor: 11.205

6.  Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.

Authors:  Ann-Marie Chacko; Jingyan Han; Colin F Greineder; Blaine J Zern; John L Mikitsh; Madhura Nayak; Divya Menon; Ian H Johnston; Mortimer Poncz; David M Eckmann; Peter F Davies; Vladimir R Muzykantov
Journal:  ACS Nano       Date:  2015-07-13       Impact factor: 15.881

7.  Multivalent binding of nanocarrier to endothelial cells under shear flow.

Authors:  Jin Liu; Neeraj J Agrawal; Andres Calderon; Portonovo S Ayyaswamy; David M Eckmann; Ravi Radhakrishnan
Journal:  Biophys J       Date:  2011-07-20       Impact factor: 4.033

8.  Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation.

Authors:  Blaine J Zern; Ann-Marie Chacko; Jin Liu; Colin F Greineder; Eric R Blankemeyer; Ravi Radhakrishnan; Vladimir Muzykantov
Journal:  ACS Nano       Date:  2013-02-08       Impact factor: 15.881

Review 9.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

10.  Ligand Density and Nanoparticle Clustering Cooperate in the Multivalent Amplification of Epidermal Growth Factor Receptor Activation.

Authors:  Qianyun Zhang; Björn M Reinhard
Journal:  ACS Nano       Date:  2018-10-11       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.